Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: A comparison of needle aspiration and needle-core biopsies to the surgical specimen

Diagnostic Cytopathology

Volumn 15, Issue 3, 1996, Pages 205-210

  Railo, Mikael ^a   Nordling, Stig ^b   Krogerus, Leena ^b   Sioris, Thanos ^b   Von Smitten, Karl ^b  

^a Maria Hospital   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; HORMONE RECEPTOR; PROGESTERONE RECEPTOR; TUMOR ANTIGEN;

ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CARCINOMA; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; NEEDLE BIOPSY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEPTOR DENSITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BIOPSY, NEEDLE; BREAST NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PREOPERATIVE CARE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SENSITIVITY AND SPECIFICITY;

EID: 0029806615     PISSN: 87551039     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0339(199609)15:3<205::AID-DC6>3.0.CO;2-F     Document Type: Article

References (29)

1. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with proliferation. Int J Cancer 1983;31:13-20.
2. Schlüter C, Duchrow M, Wohlenberg C, Becker MHG, Key G, Flad H-D, Gerdes J. The cell proliferation-associated antigen of antibody Ki67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins. J Cell Biol 1993;123:513-522.
3. Gasparini G, Pozza F, Meli S, Reitano N, Santini G, Bevilacqua P. Breast cancer kinetics: immunohistochemical determination of growths fractions by monoclonal antibody KI-67 and correlation with flow-cytometric S-phase and with some features of tumour aggressiveness. Anticancer Res 1991;11:2015-2021.
4. Stumpp J, Dietl J, Simon W, Geppert M. Growth fraction in breast carcinoma determined by KI-67 immunostaining: correlation with pathological and clinical variables. Gynecol Obstet Invest 1992;33:47-50.
5. Railo M, Nordling S, von Boguslawsky K, Leivonen M, Kyllönen L, von Smitten K. Prognostic value of Ki-67 immunolabelling in primary operable breast cancer. Br J Cancer 1993;68:579-583.
6. Veronese SM, Gambacorta M, Gottardi O, Scanzi F, Ferrari M, Lampertico P. Proliferation index as a prognostic marker in breast cancer. Cancer 1993;71:3926-3931.
7. Howat JMT, Harris M, Swindell R, Barnes DM. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br J Cancer 1985:51:263-270.
8. Kuenen-Boumeester V, Van Der Kwast TH, Van Laarhoven HA, Henzen Longmans SC. Ki-67 staining in histological subtypes of breast carcinoma and fine needle aspiration smears. J Clin Pathol 1991;44: 208-210.
9. Skoog L, Rutqvist LE, Wilking N. Analysis of hormone receptors and proliferation fraction in fine needle aspirates from primary breast carcinomas during chemotherapy or tamoxifen therapy. Acta Oncol 1992;31:139-141.
10. Henry MJ, Stanley MW, Swenson B, Connolly JE, Bates H. Cytologic assessment of tumour cell kinetics: applications of monoclonal antibody KI-67 to fine-needle aspiration smears. Diagn Cytopathol 1991;7: 591-596.
11. Bloom HJG, Richardson WW. Histological grading and prognosis in breast cancer - A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 1957;11:359-377.
12. Barrows GH, Anderson TJ, Lamb JL, Dixon JM. Fine needle aspiration of breast cancer. Relationship of clinical factors to cytology results in 689 primary malignancies. Cancer 1986;58:1493-1498.
13. Hitchcock A, Hunt CM, Locker A, Koslowski J, Strudwick S, Elston CW, Blamey RW, Ellis IO. One year audit of fine needle aspiration cytology for die preoperative diagnosis of breast disease. Cytopathology 1991;2:167-176.
14. Kline TS, Joshi LP, Neal HS. Fine needle aspiration of the breast: diagnosis and pitfalls. A review of 3545 cases. Cancer 1979;44:1458-1464.
15. Costa MJ, Tadros T, Hilton G, Birdsong G. Breast fine needle aspiration cytology. Utility as a screening tool for clinically palpable lesions. Acta Cytol 1993;37:461-471.
16. Elvecrog EL, Lechner MC, Nelson MT. Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology 1993;188:453-455.
17. McMahon AJ, Lutfy AM, Matthew A, Walls AD, McOrmick JS, Henderson MA, Auld CD. Needle core biopsy of the breast with a spring loaded device. Br J Surg 1992;79:1042-1045.
18. Parker SH, Lovin JD, Jobe WE, Luethke JM, Hopper KD, Yokes WF, Burke BJ. Stereotactic breast biopsy with a biopsy gun. Radiology 1990; 176:741-747.
19. Parker SH, Lovin JD, Jobe WE, Burke BJ, Hopper KD, Yakes WF. Non-palpable breast lesions: stereotactic automated large core biopsies with a biopsy gun. Radiology 1991;180:403-407.
20. Daidone MG, Orefice S, Mastore M, Santoro G, Salvadori B, Silvestrini R. Comparing core needle to surgical biopsies in breast cancer for cell kinetic and ploidy studies. Breast Cancer Res Treat 1991; 19:33-37.
21. Barth RJ, Merino MJ, Solomon D, Yang JC, Baker AR. A prospective study of the value of core needle biopsy and fine needle aspiration in the diagnosis of soft tissue masses. Surgery 1992;112:536-543.
22. Baildam AD, Turnbull L, Howell A, Barnes DM, Sellwood RA. Extended role for needle biopsy in the management of carcinoma of the breast. Br J Surg 1989;76:553-558.
23. Cusick JD, Dotan J, Jaecks RD, Boyle WTJ. The role of Tru-Cut needle biopsy in the diagnosis of carcinoma of the breast. Surg Gynecol Obstet 1990;170:407-410.
24. Parker SH, Jobe WE, Dennis MA, Stavros AT, Johnson KK, Yakes WF, Truell JE, Price JG, Kortz AB, Clark DG. US-guided automated large core breast biopsy. Radiology 1993;187:507-511.
25. Barreto V, Hamed H, Griffiths AB, Hanby A, Chaudary MA, Fentiman IS. Automatic needle biopsy in the diagnosis of early breast cancer. Eur J Surg Oncol 1991;17:237-239.
26. Kallioniemi OP, Hietanen T, Mattila J, Lehtinen M, Lauslahti K, Koivula T. Aneuploid DNA content and high S phase fraction are related to poor prognosis in patients with primary breast cancer. Eur J Cancer Clin Oncol 1987;23:277-282.
27. Locker AP, Birrell K, Bell JA, Nicholson RI, Elston CW, Blarney RW, Ellis IO. Ki-67 immunoreactivity in breast carcinoma: relationships to prognostic variables and short term survival. Eur J Surg Oncol 1992; 18:224-229.
28. O'Reilly SM, Camplejohn RS, Barnes DM, Millis RR, Rubens RD, Richards MA. Node negative breast cancer: prognostic subgroups defined by tumour size and flow cytometry. J Clin Oncol 1990;8: 2040-2046.
29. Dixon JM, Anderson TJ, Lamb J, Nixon SJ, Forest APM. Fine needle aspiration cytology, in relationship to clinical examination and mammography in the diagnosis of solid breast mass. Br J Surg 1984;71: 593-596.